Mind Medicine (MindMed) (MNMD) Competitors $8.88 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$8.84 -0.04 (-0.51%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD vs. TWST, DNLI, KNSA, AGIO, RXRX, CGON, VCEL, BEAM, BLTE, and IDYAShould you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Twist Bioscience (TWST), Denali Therapeutics (DNLI), Kiniksa Pharmaceuticals International (KNSA), Agios Pharmaceuticals (AGIO), Recursion Pharmaceuticals (RXRX), CG Oncology (CGON), Vericel (VCEL), Beam Therapeutics (BEAM), Belite Bio (BLTE), and IDEAYA Biosciences (IDYA). These companies are all part of the "pharmaceutical products" industry. Mind Medicine (MindMed) vs. Its Competitors Twist Bioscience Denali Therapeutics Kiniksa Pharmaceuticals International Agios Pharmaceuticals Recursion Pharmaceuticals CG Oncology Vericel Beam Therapeutics Belite Bio IDEAYA Biosciences Twist Bioscience (NASDAQ:TWST) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations. Which has more volatility and risk, TWST or MNMD? Twist Bioscience has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.45, meaning that its stock price is 145% more volatile than the S&P 500. Which has better valuation & earnings, TWST or MNMD? Mind Medicine (MindMed) has lower revenue, but higher earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Mind Medicine (MindMed), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$312.97M6.73-$208.73M-$3.25-10.82Mind Medicine (MindMed)N/AN/A-$108.68M-$1.29-6.88 Do institutionals & insiders have more ownership in TWST or MNMD? 27.9% of Mind Medicine (MindMed) shares are owned by institutional investors. 3.0% of Twist Bioscience shares are owned by insiders. Comparatively, 2.5% of Mind Medicine (MindMed) shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is TWST or MNMD more profitable? Mind Medicine (MindMed) has a net margin of 0.00% compared to Twist Bioscience's net margin of -54.98%. Twist Bioscience's return on equity of -33.48% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-54.98% -33.48% -25.34% Mind Medicine (MindMed) N/A -40.33%-32.13% Do analysts rate TWST or MNMD? Twist Bioscience currently has a consensus price target of $50.40, indicating a potential upside of 43.30%. Mind Medicine (MindMed) has a consensus price target of $25.50, indicating a potential upside of 187.16%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Mind Medicine (MindMed) 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 3 Strong Buy rating(s) 3.27 Does the media favor TWST or MNMD? In the previous week, Twist Bioscience had 3 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 5 mentions for Twist Bioscience and 2 mentions for Mind Medicine (MindMed). Mind Medicine (MindMed)'s average media sentiment score of 1.26 beat Twist Bioscience's score of 0.68 indicating that Mind Medicine (MindMed) is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Mind Medicine (MindMed) 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMind Medicine (MindMed) beats Twist Bioscience on 9 of the 14 factors compared between the two stocks. Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MNMD vs. The Competition Export to ExcelMetricMind Medicine (MindMed)MED IndustryMedical SectorNASDAQ ExchangeMarket Cap$670.91M$2.91B$5.52B$9.41BDividend YieldN/A2.45%3.80%4.04%P/E RatioN/A19.8828.0419.84Price / SalesN/A305.11429.5399.59Price / CashN/A43.1635.8457.94Price / Book2.777.678.125.65Net Income-$108.68M-$55.28M$3.25B$258.00M7 Day Performance10.17%2.50%0.97%2.09%1 Month Performance25.25%11.70%7.36%11.13%1 Year Performance7.90%4.89%31.31%18.40% Mind Medicine (MindMed) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MNMDMind Medicine (MindMed)2.1255 of 5 stars$8.88flat$25.50+187.2%+5.8%$670.91MN/A-6.8840Positive NewsTWSTTwist Bioscience4.227 of 5 stars$35.59-6.8%$50.40+41.6%-36.2%$2.13B$312.97M-10.95990News CoverageDNLIDenali Therapeutics4.537 of 5 stars$14.25-3.0%$33.71+136.6%-36.9%$2.07B$330.53M-5.34430KNSAKiniksa Pharmaceuticals International3.3535 of 5 stars$27.95+0.3%$38.80+38.8%+34.7%$2.04B$481.17M-111.80220Upcoming EarningsInsider TradeAGIOAgios Pharmaceuticals4.409 of 5 stars$35.21-2.4%$58.60+66.4%-14.4%$2.04B$36.50M3.13390RXRXRecursion Pharmaceuticals1.1261 of 5 stars$4.93-6.5%$7.00+42.0%-33.9%$2.00B$58.84M-2.79400Gap UpHigh Trading VolumeCGONCG Oncology2.531 of 5 stars$26.25-2.4%$58.67+123.5%-25.5%$2.00B$662K-17.3861News CoverageAnalyst ForecastVCELVericel3.6832 of 5 stars$39.41-5.6%$61.14+55.1%-29.9%$1.98B$237.22M1,314.10300News CoveragePositive NewsBEAMBeam Therapeutics2.0658 of 5 stars$19.18-4.1%$48.75+154.2%-24.1%$1.93B$63.52M-4.16510Gap UpBLTEBelite Bio1.831 of 5 stars$58.63-1.4%$96.67+64.9%+26.6%$1.87BN/A-43.1110IDYAIDEAYA Biosciences3.5047 of 5 stars$21.16-4.3%$53.42+152.4%-45.7%$1.85B$7M-5.8980Positive News Related Companies and Tools Related Companies TWST Alternatives DNLI Alternatives KNSA Alternatives AGIO Alternatives RXRX Alternatives CGON Alternatives VCEL Alternatives BEAM Alternatives BLTE Alternatives IDYA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MNMD) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.